Partner with us

MILESTONE:  Ailux enters into a license agreement with Janssen on biologics AI

Illuminating Biologics Discovery with AI

Scroll and explore

PURPOSE

Ailux represents a groundbreaking approach that synergizes the strengths of AI, wet lab, and proprietary data to drive biologics discovery.

Our AI-powered platforms empower partners to achieve greater R&D success on the path toward the clinic.

VIRTUAL TOUR

 Technology

World-leading biologics AI models powered by a massive, proprietary biologics dataset

EXPLORE OUR TECHNOLOGY
  • 01 AI ENGINES
  • 02 WET LAB
  • 03 DATABASE
  • Model

    protein complex structures to inform candidate selection and engineering.

  • Generate

    developable biologics sequences with specified profile.

  • Predict

    key properties to prioritize candidates without making them.

A state-of-the-art wet lab underpins our advanced AI models and one-stop solutions for partners.

Proprietary biologics database tailor-made for AI

AtlaX

Public dataset

Data size

Granularity

Label-Free
Qualitative
Quantitative

Seq

Binder

Develop-ability

KD

Epitope

Trend line

Bubble size proportional to cost of data


  • Model protein complex structures to inform candidate selection and engineering.

  • Generate developable biologics sequences with specified profile.

  • Predict key properties to prioritize candidates without making them.


A state-of-the-art wet lab underpins our advanced AI models and one-stop solutions for partners.


Proprietary biologics database tailor-made for AI

AtlaX

Public dataset

Data size

Granularity

Label-Free
Qualitative
Quantitative

Seq

Binder

Develop-ability

KD

Epitope

Trend line

Bubble size proportional to cost of data

APPLICATIONS

Addressing key bottlenecks in biologics discovery

HOW WE DELIVER VALUE

HARD TARGETS

NEXT-GEN ENGINEERING

RAISE THE BAR

ADVANCED MODALITIES

news & events

Explore our upcoming news & events

PARTNERSHIP

Are you ready to push the boundaries of what’s possible? We are here to help you tackle difficult targets and optimize critical leads

Partner with us
ailux xtalpi
Case Study

Tapping into a greater search space for more quality hits using AI.

Immune Repertoire Analysis

In silico screening of millions of antibody sequences in the immune repertoire 

K+
VL Clonotypes
K+
VH Clonotypes
Animals
NCS Datasets
M+
Unique VL Sequences
M+
Unique VH Sequences
Results and Insights

XploreSeqTM Identifies Hits with High Accuracy

XploreSeqTM routinely sequences millions of BCRs and identifies hits with high confidence (see figure). In this project, XploreSeq predicted 717 binders, from which 48 were randomly chosen for expression and testing. 66.7% (32/48) were confirmed to be binders, and only 18.6% (6/32) binders overlap with hybridoma hits.

Read more case studies
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from - Youtube
Vimeo
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Spotify
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound
Save